Home » Topics » BioWorld Science

BioWorld Science
RSS

Lilly initiates phase II study of LY-3303560 in early symptomatic AD

May 28, 2018

First patient enrolled in SARA-INT study of Sarconeos in sarcopenia

May 28, 2018

Discovery of novel inhibitor of human NMT for treatment of the common cold

May 28, 2018

Bionomics initiates phase II study of BNC-210 for the treatment of agitation in elderly

May 28, 2018

New phase I trial studies GD2-specific CAR and IL-15 expressing NKTs in neuroblastoma

May 28, 2018

Atridia begins phase I study of SHR-0410 in healthy volunteers

May 28, 2018

Researchers create a renal medullary carcinoma mouse model for chemotherapy testing

May 25, 2018

Voyager Therapeutics develops AAV gene therapy for Friedreich's ataxia

May 25, 2018

License agreement and collaborations support development of human Nipah virus vaccine

May 25, 2018

Ficolin binding inhibitors patented by Osaka University

May 25, 2018

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...